Filing Flows › Comparisons › EVH vs FC
Evolent Health vs Franklin Covey: EVH and FC compared
Evolent Health is the larger company: $725M of revenue in its latest quarter (Q3 2026) against $70.0M for Franklin Covey (Q4 FY26). Evolent Health is growing faster (+51% against -2% a year earlier). Franklin Covey is more profitable, with an operating margin of 12.3% against -0.9%.
Where the money goes: EVH and FC
Evolent Health (EVH) · Q3 2026
Evolent Health, Q3 2026: revenue $725M (+51% year over year), operating margin -0.9%, net loss $23.6M, operating cash flow $26.4M. The chart follows the revenue to costs, profit and cash.
Franklin Covey (FC) · Q4 FY26
Franklin Covey, Q4 FY26: revenue $70.0M (-2% year over year), operating margin 12.3%, net earnings $7.1M, operating cash flow $4.1M. The chart follows the revenue to costs, profit and cash.
| Evolent Health (EVH) | Franklin Covey (FC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q4 FY26 |
| Revenue | $725M | $70.0M |
| Revenue growth, Y/Y | +51% | -2% |
| Gross margin | — | 74.7% |
| Operating margin | -0.9% | 12.3% |
| Net earnings | −$23.6M | $7.1M |
| Net margin | -3.2% | 10.2% |
| Operating cash flow | $26.4M | $4.1M |
| Free cash flow | — | $2.7M |
| Market value | $518M | — |
| Analysts’ mean target | $5.83 | — |
Where the revenue comes from
Franklin Covey
- North America: $35.8M (51%)
- Education Division: $23.6M (34%)
- International: $9.7M (14%)
- Corporate and other: $872K (1%)
Questions
Which is bigger, Evolent Health or Franklin Covey?
Evolent Health is the larger company: $725M of revenue in its latest quarter (Q3 2026) against $70.0M for Franklin Covey (Q4 FY26).
Is Evolent Health or Franklin Covey growing faster?
Evolent Health is growing faster (+51% against -2% a year earlier).
Which is more profitable, Evolent Health or Franklin Covey?
Franklin Covey is more profitable, with an operating margin of 12.3% against -0.9%.
More: Evolent Health earnings · how Evolent Health makes money · Franklin Covey earnings · how Franklin Covey makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 8-K filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.